First left-right comparative study of topical rapamycin vs. vehicle for facial angiofibromas in patients with tuberous sclerosis complex.

Tanaka, M; Wataya-Kaneda, M; Nakamura, A; Matsumoto, S; Katayama, I

Tanaka, M; Wataya-Kaneda, M; Nakamura, A; Matsumoto, S; Katayama, I.

Affiliation

Tanaka M; Department of Dermatology, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan.

Br J Dermatol ; 169(6): 1314-8, 2013 Dec.

Article in En | MEDLINE | ID: mdl-23909960

Subject(s)

Angiofibroma/drug therapy; Antibiotics, Antineoplastic/administration & dosage; Facial Neoplasms/drug therapy; Sirolimus/administration & dosage; Tuberous Sclerosis/complications; Administration, Cutaneous; Adolescent; Adult; Angiofibroma/complications; Child; Child, Preschool; Facial Neoplasms/complications; Female; Gels/administration & dosage; Humans; Male; Neoplasm Recurrence, Local/etiology; Ointments/administration & dosage; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberous Sclerosis / Facial Neoplasms / Angiofibroma / Sirolimus / Antibiotics, Antineoplastic Type of study: Etiology_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Language: En Journal: Br J Dermatol Year: 2013 Type: Article Affiliation country: Japan

Fulltext

XML

PubMed Links

Search on Google